查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2093310

軟體市場作為醫療設備－2026-2032年全球市場預測

Software as a Medical Device Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，「醫療設備軟體」市場將成長至 104.7 億美元，複合年成長率為 7.45%。

主要市場統計數據
基準年 2025 63.3億美元
預計年份：2026年 67.7億美元
預測年份 2032 104.7億美元
複合年成長率 (%) 7.45%

軟體即醫療設備(SaMD)執行摘要

軟體即醫療設備(SaMD) 正在改變醫療服務模式，它無需實體醫療設備即可實現軟體主導的診斷、監測、臨床決策支援、疾病管理和個人化治療。隨著醫療系統採用數位健康平台、遠端患者監護、行動醫療應用、基於雲端的臨床工作流程和互聯醫療模式，SaMD 的重要性日益凸顯。監管機構根據 SaMD 的預期醫療用途進行定義，臨床相關性、網路安全、易用性、互通性和上市後表現是產品成功的關鍵因素。慢性病負擔日益加重、遠距遠端醫療應用日益普及、臨床數據可用性不斷提高，以及對可擴展工具的需求不斷成長（這些工具既能改善醫療服務的可及性，又能支持循證決策），都推動了 SaMD 的發展。隨著醫院、保險公司、生命科學公司和數位健康開發商推動軟體主導的醫療路徑，SaMD 正從獨立應用演變為整合、人工智慧賦能、可互通的生態系統，這些生態系統必須滿足嚴格的安全性、有效性、透明度和生命週期管理標準。

SaMD領域的變革性變化

隨著醫療機構從孤立的、以機構為中心的護理模式轉向持續的、數據驅動的、以患者為中心的模式，軟體即肌肉（SaMD）領域正在經歷一場變革。雲端技術的應用、應用程式介面（API）、與電子健康記錄健康記錄的整合以及穿戴式裝置產生的數據，正在拓展軟體支援臨床工作流程（涵蓋預防、診斷、治療和追蹤）的範圍。監管要求也在變化，越來越重視品管系統、軟體生命週期文件、實際效能監測、網路安全風險管理和人因工程。同時，報銷和採購決策也更加重視實證醫學，要求開發人員證明其臨床效用、工作流程契合度、健康經濟價值以及在不同病患小組中的公平性。互通性標準、隱私設計架構和安全資料交換不再只是技術選項，而是策略要求。這些變化正在創造一個更成熟的SaMD環境，在這個環境中，結合了檢驗的演算法、直覺的使用者體驗、合規應對力和可衡量的臨床結果的解決方案能夠蓬勃發展。

人工智慧對軟體即醫療器材（SaMD）的累積影響

人工智慧 (AI) 正在放大「醫療設備軟體 (SaMD)」帶來的機會和挑戰。 AI 驅動的 SaMD 可以支援影像分析、風險預測、分診、遠端監測、數位療法、疾病進展建模和個人化臨床建議。其累積影響最顯著地體現在從基於規則的軟體轉向能夠識別多模態健康資料集模式的自適應、資料密集型系統的轉變。然而，利用 AI 也帶來了一些關鍵要求，例如演算法透明度、資料集代表性、偏差緩解、臨床有效性、可解釋性、網路安全性以及部署後持續的效能監測。監管機構越來越關注預先定義的變更管理、正確的機器學習實施以及真實世界證據，以管理基於 AI 的醫療軟體的生命週期。對於行業領導者而言，AI 不僅僅是功能增強；它帶來了跨領域的管治挑戰，涵蓋臨床科學、監管事務、資料工程、倫理、隱私和品質保證。

關於SaMD實施的關鍵區域見解

亞太地區是軟體即醫療器材（SaMD）應用的優先區域，這得益於其不斷擴展的數位醫療基礎設施、龐大的患者群體、日益普及的智慧型手機以及政府主導的醫療現代化舉措。該地區各國正在加強醫療軟體的法規結構，醫院和保險公司也在探索採用遠端監測、人工智慧輔助診斷和行動醫療工具，以解決醫療服務取得方面的不平等和專科醫生短缺問題。歐洲的特點是醫療設備器材法規嚴格、資料保護規則完善，並專注於在不斷變化的監管要求下實現互通性、臨床安全性和合規性評估。北美仍然是一個高度發展的SaMD環境，這得益於成熟的數位醫療應用、完善的監管流程、電子健康記錄的廣泛使用以及對人工智慧驅動的臨床應用的大力投資。在這裡，臨床證據、網路安全、資料隱私以及與保險報銷系統的協調尤為重要。拉丁美洲正透過遠端醫療的擴展、公共衛生的數位化以及對擴充性慢性病管理工具日益成長的興趣取得進展，但基礎設施的差異和分散的保險報銷系統可能會影響其應用。在非洲，行動優先醫療、數位公共衛生平台和遠距醫療工具具有巨大的長期潛力，能夠有效解決人力資源和基礎設施的限制。然而，這些技術的成功實施取決於通訊基礎設施、可負擔性、監管合規性和本地臨床檢驗。在中東，國家衛生策略、醫院現代化、智慧城市計畫以及對互聯醫療的投資正在加速推進數位醫療轉型，使得軟體驅動醫療（SaMD）在遠距醫療、慢性病監測和數位化驅動的專科醫療方面變得日益重要。

全球SaMD市場關鍵群體分析

北約成員國中包括一些擁有先進數位醫療系統的國家。在這些國家，由於醫療基礎設施的高度敏感性以及針對醫療軟體生態系統的網路威脅風險日益增加，網路安全韌性、安全的雲端基礎設施和可靠的資料交換尤為重要。七國集團（G7）國家普遍擁有先進的醫療資訊IT基礎設施和強大的研究生態系統，對實證數位醫療的期望日益成長，包括人工智慧管治、隱私保護以及與醫療系統的整合。金磚國家擁有龐大的人口、醫療數位化進程的推進、國內創新政策以及對經濟實惠且擴充性的醫療軟體日益成長的需求，這些都為其提供了廣闊的發展機遇，但本地化的法規和複雜的採購流程需要製定針對特定國家的戰略。歐盟擁有最完善的軟體即醫療器材（SaMD）法規環境之一，重點關注醫療設備合規性、臨床評估、上市後監管、網路安全和個人資料保護，因此，監管合規規劃和證據累積對於市場准入至關重要。在東南亞國協，隨著各國政府大力推廣數位醫療、跨國醫療合作和行動優先的存取模式，軟體即醫療器材的重要性日益凸顯。然而，各成員國監管成熟度的差異，要求制定能夠適應不同情況的彈性合規策略。在海灣合作理事會國家，軟體即醫療器材（SaMD）的發展受到國家數位健康計劃、醫院數位化、人工智慧應用以及對高品質醫療服務（尤其是在慢性病管理、遠端患者監護和臨床工作流程最佳化方面）的需求的推動。

主要國家對醫療設備軟體（SaMD）的見解

在中國，憑藉大規模的臨床資料集、醫院數位化進程的推進以及不斷完善的法律規範（其中數據管治和本地合規是關鍵因素），數位醫療和人工智慧醫療軟體領域的能力正在迅速提升。美國是軟體即醫療器材（SaMD）的主要市場，這得益於其成熟的數位醫療應用、積極的醫療軟體法律規範、人工智慧驅動的臨床應用案例的不斷擴展，以及對網路安全和實際應用性能日益成長的關注。日本正日益重視遠端監測、診斷、復健和慢性病管理領域的軟體即醫療器械，這得益於其先進的醫療基礎設施、老齡化社會的需求以及嚴格的監管要求。印度憑藉其數位公共基礎設施、遠端醫療的普及、行動醫療平台的推廣以及對適用於不同醫療環境的經濟型診斷和監測工具的需求，正蓬勃發展。德國的特點是醫療設備法規嚴格、數位醫療保險報銷體系完善、對隱私保護要求高，以及對經過臨床檢驗的數位治療和診斷軟體的需求。英國擁有健全的數位健康政策環境和完善的醫療技術評估機制，並日益重視人工智慧保障、臨床安全標準以及與國家醫療工作流程的整合。澳洲透過重點發展電子健康記錄、推廣遠端醫療、完善隱私法規以及改善偏遠和農村地區的醫療服務可近性，支持軟體即醫療（SaMD）的普及。法國透過其數位健康策略、針對特定數位醫療技術的報銷機制以及對臨床證據、資料保護和醫療互通性的重視，支持軟體即醫療的發展。韓國定位為以創新為導向的軟體即醫療環境，擁有先進的網路連接、數位化醫院能力、人工智慧研究活動以及支援醫療軟體檢驗和商業化的監管措施。義大利和西班牙透過社區醫療數位化、遠端醫療的擴展以及對支持慢性病管理、提高醫院效率和遠端監測的工具的關注，推動軟體即醫療的普及。加拿大透過專注於患者安全、醫療技術評估、隱私合規性和省級醫療系統中的公平獲取，支持對檢驗且可互通的軟體即醫療解決方案的需求。俄羅斯的軟體即醫療器材（SaMD）環境主要受其國內數位醫療產業的現代化和在地化、對遠端醫療和診斷支援工具日益成長的需求以及監管合規和數據管治等核心挑戰的驅動。巴西是拉丁美洲最具活力的數位醫療環境之一，其大規模的醫療保健需求、遠端醫療的普及以及監管機構對醫療軟體的重視，為慢性病管理和遠距醫療提供了發展機會。墨西哥的遠端保健發展迅速，數位化醫院計畫不斷推進，對改善專科會診服務的工具需求也日益成長，但監管合規和醫療體系碎片化仍然是需要重點考慮的問題。在西班牙，數位醫療的現代化、地方層面醫療協調工作的推進以及遠距遠端保健服務的日益普及，正在推動對安全可靠的SaMD解決方案的需求，以支持慢性病護理、診斷和臨床工作流程的簡化。

為SaMD產業領導者提供的實用建議

行業領導者應優先考慮監管策略，從產品開發的早期階段就將預期用途、風險分類、臨床評估、網路安全措施和上市後監測與目標司法管轄區的要求相匹配。軟體即醫療器材 (SaMD) 開發人員應將證據產生納入產品生命週期，透過前瞻性研究、真實世界效能監測、可用性測試和衛生經濟學分析來證明其臨床價值和工作流程相關性。人工智慧驅動的 SaMD 需要強大的資料管治、偏差測試、可解釋性、模型版本控制和記錄在案的變更管理，以確保其可靠性和合規性。領導者應利用廣泛認可的醫療保健數據標準和安全 API，並在設計時充分考慮互通性，以減少醫院、保險公司和數位健康平台採用該技術所面臨的障礙。網路安全必須被視為一項持續的安全要求，包括威脅建模、漏洞管理、安全軟體開發和事件回應能力。銷售團隊應根據不同地區最佳化其市場推廣策略，並考慮報銷途徑、採購結構、語言在地化、臨床實務差異和資料居住需求。與臨床醫生、醫療保健系統、患者團體和監管機構夥伴關係可以加快檢驗、實施和負責任的規模化。

SaMD Insights 的調查方法

本執行摘要基於系統的二手研究途徑，重點關注檢驗的、公開可用的且與行業相關的資訊來源。該調查方法包括對醫療設備軟體監管指南、數位健康政策文件、臨床安全標準、網路安全框架、互通性要求、醫療技術評估資料、同行評審文獻和政府出版刊物的審查。透過評估監管成熟度、醫療保健數位化、遠距醫療應用、遠端醫療管治活動、資料保護要求、網路安全準備、報銷機制和基礎設施準備情況，整合了區域、群體和國家層面的洞察。本分析不涉及市場規模、市場佔有率和預測，而是著重於定性促進因素、應用趨勢、合規性考量和策略意義。所有研究結果均盡可能與權威資訊來源進行交叉核對，以確保其一致性、相關性和決策效用，從而幫助相關人員評估醫療設備軟體領域的商業機會。

結論：軟體作為醫療設備的未來

隨著醫療服務提供者、保險公司和患者對更便利、更智慧、更持續的醫療解決方案的需求日益成長，醫療軟體即醫療設備（SaMD）正成為現代醫療保健的核心組成部分。該領域正透過人工智慧驅動的診斷、遠端監測、數位療法、雲端工作流程和可互通的臨床決策支援不斷發展，但要持續成功，必須進行嚴格的臨床檢驗、遵守法規、確保網路安全、保護隱私並進行上市後監管。不同地區在基礎設施、報銷體系、資料管治和監管成熟度方面的差異，要求制定量身定做的策略。同時，隨著全球對安全性、有效性、透明度和真實世界證據的日益重視，對所有開發者的期望也不斷提高。那些能夠將可靠的醫學證據、安全的工程設計、以臨床醫生為中心的設計以及負責任的人工智慧管治相結合的機構，最有能力提供可靠的SaMD解決方案，從而改善治療效果並增強醫療保健系統的韌性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：醫療設備軟體市場：依分銷模式分類

  • 移動基地
  • 獨立版
  • 基於網路的

第8章：醫療設備軟體市場：功能性

  • 診斷
  • 監測
  • 預防
  • 治療領域

第9章：醫療設備軟體市場：依風險分類

  • 一級
  • 二類
  • 三級

第10章：醫療設備軟體市場：依資料輸入類型分類

  • 醫學影像診斷
  • 生理訊號
  • 檢測和基因組數據
  • 患者報告結果

第11章：醫療設備軟體市場：依治療領域分類

  • 循環系統
    • 心律不整監測
    • 血壓監測
    • 心臟衰竭管理
  • 糖尿病管理
    • 血糖監測
    • 胰島素劑量
    • 營養管理
  • 神經病學
  • 整形外科
  • 呼吸系統

第12章：醫療設備軟體市場：依最終用戶分類

  • 門診治療
  • 診所
  • 居家照護
  • 醫院
  • 臨床研究機構

第13章：醫療設備軟體市場：按地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第14章：醫療設備軟體市場：依類別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第15章：醫療設備軟體市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • AliveCor, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cisco Systems, Inc.
  • DexCom Inc.
  • Edwards Lifesciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • Honeywell International Inc.
  • IBM Corporation
  • Intel Corporation
  • Intuitive Surgical, Inc.
  • iRhythm Technologies, Inc.
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic plc
  • Microsoft Corporation
  • Omron Healthcare, Inc.
  • Oracle Corporation
  • Qualcomm Life, Inc.
  • ResMed Inc.
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-8903005C4A47

The Software as a Medical Device Market is projected to grow by USD 10.47 billion at a CAGR of 7.45% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.33 billion
Estimated Year [2026] USD 6.77 billion
Forecast Year [2032] USD 10.47 billion
CAGR (%) 7.45%

Software as a Medical Device Executive Summary

Software as a Medical Device (SaMD) is reshaping healthcare delivery by enabling software-driven diagnosis, monitoring, clinical decision support, disease management, and personalized therapy without being part of a physical medical device. The category is increasingly important as health systems adopt digital health platforms, remote patient monitoring, mobile health applications, cloud-based clinical workflows, and connected care models. Regulatory bodies define SaMD by its intended medical purpose, making clinical validity, cybersecurity, usability, interoperability, and post-market performance central to product success. Demand is supported by rising chronic disease burden, expanding telehealth use, growing clinical data availability, and the need for scalable tools that improve access to care while supporting evidence-based decisions. As hospitals, payers, life sciences organizations, and digital health developers advance software-led care pathways, SaMD is moving from standalone applications toward integrated, AI-enabled, interoperable ecosystems that must meet rigorous standards for safety, effectiveness, transparency, and lifecycle management.

Transformative Shifts in the SaMD Landscape

The SaMD landscape is undergoing transformative shifts as healthcare organizations move from episodic, facility-based care toward continuous, data-driven, and patient-centered models. Cloud deployment, application programming interfaces, electronic health record integration, and wearable-generated data are expanding how software supports clinical workflows across prevention, diagnosis, treatment, and follow-up. Regulatory expectations are also evolving, with increasing emphasis on quality management systems, software lifecycle documentation, real-world performance monitoring, cybersecurity risk management, and human factors engineering. At the same time, reimbursement and procurement decisions are becoming more evidence-driven, requiring developers to demonstrate clinical utility, workflow fit, health economic value, and equity across diverse patient groups. Interoperability standards, privacy-by-design architecture, and secure data exchange are now strategic requirements rather than technical options. These shifts are creating a more mature SaMD environment in which successful solutions combine validated algorithms, intuitive user experience, regulatory readiness, and measurable clinical outcomes.

Cumulative Impact of Artificial Intelligence on SaMD

Artificial intelligence is amplifying both the opportunities and responsibilities associated with Software as a Medical Device. AI-enabled SaMD can assist in image analysis, risk prediction, triage, remote monitoring, digital therapeutics, disease progression modeling, and personalized clinical recommendations. Its cumulative impact is most visible in the transition from rule-based software to adaptive, data-intensive systems that can identify patterns across multimodal health datasets. However, the use of AI also raises critical requirements for algorithm transparency, dataset representativeness, bias mitigation, clinical validation, explainability, cybersecurity, and ongoing performance monitoring after deployment. Regulators have increasingly focused on predetermined change control, good machine learning practices, and real-world evidence to manage the lifecycle of AI-based medical software. For industry leaders, AI is not simply a feature enhancement; it is a governance challenge that requires cross-functional oversight across clinical science, regulatory affairs, data engineering, ethics, privacy, and quality assurance.

Key Regional Insights for SaMD Adoption

Asia-Pacific is a high-priority region for SaMD adoption due to expanding digital health infrastructure, large patient populations, increasing smartphone penetration, and government-backed healthcare modernization initiatives. Countries across the region are strengthening regulatory frameworks for medical software, while hospitals and payers are exploring remote monitoring, AI-assisted diagnostics, and mobile health tools to address access gaps and specialist shortages. Europe is characterized by rigorous medical device regulation, strong data protection rules, and a focus on interoperability, clinical safety, and conformity assessment under evolving regulatory requirements. North America remains a highly advanced SaMD environment supported by mature digital health adoption, established regulatory pathways, high use of electronic health records, and strong investment in AI-enabled clinical applications, with significant emphasis on clinical evidence, cybersecurity, data privacy, and reimbursement alignment. Latin America is advancing through telehealth expansion, public health digitization, and growing interest in scalable tools for chronic disease management, although infrastructure variability and fragmented reimbursement can affect implementation. Africa presents meaningful long-term potential as mobile-first healthcare, digital public health platforms, and remote consultation tools address workforce and infrastructure constraints, though adoption depends on connectivity, affordability, regulatory capacity, and localized clinical validation. The Middle East is accelerating digital health transformation through national health strategies, hospital modernization, smart city initiatives, and investments in connected care, with SaMD increasingly relevant for remote access, chronic disease monitoring, and digitally enabled specialty care.

Key Group Insights Across Global SaMD Markets

NATO member countries include several advanced digital health systems where cybersecurity resilience, secure cloud infrastructure, and trusted data exchange are especially important due to the sensitivity of healthcare infrastructure and the growing risk of cyber threats targeting medical software ecosystems. G7 countries generally show advanced healthcare IT infrastructure, strong research ecosystems, and heightened expectations for evidence-based digital medicine, including AI governance, privacy protection, and health system integration. BRICS economies represent a broad opportunity set shaped by large populations, rising healthcare digitization, domestic innovation policies, and growing demand for affordable, scalable medical software, while regulatory localization and procurement complexity require country-specific strategies. The European Union is one of the most structured regulatory environments for SaMD, with strong emphasis on medical device conformity, clinical evaluation, post-market surveillance, cybersecurity, and personal data protection, making regulatory planning and evidence generation essential for market entry. ASEAN countries are increasingly important for SaMD as governments promote digital health, cross-border healthcare collaboration, and mobile-first access models, while diverse regulatory maturity across member states creates a need for adaptable compliance strategies. The GCC is advancing SaMD through national digital health programs, hospital digitization, AI adoption, and demand for high-quality care delivery, particularly in chronic disease management, remote patient monitoring, and clinical workflow optimization.

Key Country Insights for Software as a Medical Device

China is rapidly expanding digital health and AI medical software capabilities, supported by large clinical datasets, strong hospital digitization, and evolving regulatory oversight, though data governance and local compliance are decisive. The United States is a leading SaMD environment due to established digital health adoption, active regulatory oversight for medical software, expanding AI-enabled clinical use cases, and increasing attention to cybersecurity and real-world performance. Japan combines advanced healthcare infrastructure, aging population needs, and strong regulatory expectations, creating relevance for SaMD in remote monitoring, diagnostics, rehabilitation, and chronic care. India is gaining momentum through digital public infrastructure, telemedicine adoption, mobile health platforms, and demand for affordable diagnostic and monitoring tools suited to diverse care settings. Germany is shaped by rigorous medical device regulation, digital health reimbursement pathways, strong privacy expectations, and demand for clinically validated digital therapeutics and diagnostic software. The United Kingdom has a strong digital health policy environment, established health technology evaluation mechanisms, and growing focus on AI assurance, clinical safety standards, and integration with national healthcare workflows. Australia supports SaMD adoption through digital health records, telehealth acceptance, privacy regulation, and interest in improving care access across remote and regional communities. France supports SaMD through digital health strategy, reimbursement mechanisms for selected digital medical technologies, and emphasis on clinical evidence, data protection, and healthcare interoperability. South Korea is positioned as an innovation-focused SaMD environment with advanced connectivity, digital hospital capabilities, AI research activity, and regulatory initiatives supporting medical software validation and commercialization. Italy and Spain are advancing adoption through regional healthcare digitization, telehealth expansion, and interest in tools that support chronic disease care, hospital efficiency, and remote monitoring. Canada emphasizes patient safety, health technology assessment, privacy compliance, and equitable access across provincial health systems, supporting demand for validated and interoperable SaMD solutions. Russia's SaMD environment is influenced by domestic digital health modernization, localization priorities, and demand for telemedicine and diagnostic support tools, with regulatory compliance and data governance remaining central. Brazil is one of Latin America's most dynamic digital health environments, supported by large-scale healthcare demand, telemedicine adoption, and regulatory attention to medical software, with opportunities in chronic disease management and remote care. Mexico is advancing through telehealth growth, digital hospital initiatives, and demand for tools that improve access to specialist care, while regulatory navigation and healthcare system fragmentation remain important considerations. Spain benefits from digital health modernization, regional care coordination initiatives, and rising use of telehealth-enabled services, creating demand for secure SaMD solutions that support chronic care, diagnostics, and clinical workflow efficiency.

Actionable Recommendations for SaMD Industry Leaders

Industry leaders should prioritize regulatory strategy early in product development by aligning intended use, risk classification, clinical evaluation, cybersecurity controls, and post-market surveillance with target jurisdiction requirements. SaMD developers should build evidence generation into the product lifecycle, using prospective studies, real-world performance monitoring, usability testing, and health economic analysis to demonstrate clinical value and workflow relevance. AI-enabled SaMD requires robust data governance, bias testing, explainability, model version control, and documented change management to support trust and compliance. Leaders should design for interoperability using recognized health data standards and secure APIs to reduce implementation friction across hospitals, payers, and digital health platforms. Cybersecurity must be treated as a continuous safety requirement, including threat modeling, vulnerability management, secure software development, and incident response readiness. Commercial teams should tailor go-to-market strategies by region, accounting for reimbursement pathways, procurement structures, language localization, clinical practice differences, and data residency requirements. Partnerships with clinicians, health systems, patient groups, and regulators can accelerate validation, adoption, and responsible scaling.

Research Methodology for SaMD Insights

This executive summary is developed through a structured secondary research approach focused on verified, publicly available, and industry-relevant sources. The methodology includes review of regulatory guidance for medical device software, digital health policy documents, clinical safety standards, cybersecurity frameworks, interoperability requirements, health technology assessment materials, peer-reviewed literature, and government publications. Regional, group, and country insights are synthesized by assessing regulatory maturity, healthcare digitization, telehealth adoption, AI governance activity, data protection requirements, cybersecurity readiness, reimbursement mechanisms, and infrastructure readiness. The analysis avoids market sizing, market share, and forecasting and instead focuses on qualitative drivers, adoption dynamics, compliance considerations, and strategic implications. All insights are triangulated across authoritative sources where possible to ensure consistency, relevance, and decision usefulness for stakeholders evaluating Software as a Medical Device opportunities.

Conclusion: The Future of Software as a Medical Device

Software as a Medical Device is becoming a core component of modern healthcare as providers, payers, and patients seek more accessible, intelligent, and continuous care solutions. The sector is advancing through AI-enabled diagnostics, remote monitoring, digital therapeutics, cloud-based workflows, and interoperable clinical decision support, but sustainable success depends on rigorous clinical validation, regulatory compliance, cybersecurity, privacy protection, and post-market oversight. Regional differences in infrastructure, reimbursement, data governance, and regulatory maturity require tailored strategies, while global convergence around safety, effectiveness, transparency, and real-world evidence is raising expectations for all developers. Organizations that combine strong medical evidence, secure engineering, clinician-centered design, and responsible AI governance will be best positioned to deliver trusted SaMD solutions that improve outcomes and strengthen healthcare system resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Software as a Medical Device Market, by Delivery Mode

  • 7.1. Introduction
  • 7.2. Mobile Based
  • 7.3. Standalone
  • 7.4. Web Based

8. Software as a Medical Device Market, by Functionality

  • 8.1. Introduction
  • 8.2. Diagnostic
  • 8.3. Monitoring
  • 8.4. Prevention
  • 8.5. Therapeutic

9. Software as a Medical Device Market, by Risk Classification

  • 9.1. Introduction
  • 9.2. Class I
  • 9.3. Class II
  • 9.4. Class III

10. Software as a Medical Device Market, by Data Input Type

  • 10.1. Introduction
  • 10.2. Medical Imaging
  • 10.3. Physiological Signals
  • 10.4. Laboratory & Genomic Data
  • 10.5. Patient-Reported Outcomes

11. Software as a Medical Device Market, by Therapeutic Area

  • 11.1. Introduction
  • 11.2. Cardiology
    • 11.2.1. Arrhythmia Monitoring
    • 11.2.2. Blood Pressure Monitoring
    • 11.2.3. Heart Failure Management
  • 11.3. Diabetes Management
    • 11.3.1. Glucose Monitoring
    • 11.3.2. Insulin Dosing
    • 11.3.3. Nutritional Management
  • 11.4. Neurology
  • 11.5. Orthopedic
  • 11.6. Respiratory

12. Software as a Medical Device Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Care
  • 12.3. Clinics
  • 12.4. Home Care
  • 12.5. Hospitals
  • 12.6. Clinical Research Organizations

13. Software as a Medical Device Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. Europe
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Africa
  • 13.6. Middle East

14. Software as a Medical Device Market, by Group

  • 14.1. NATO
  • 14.2. G7
  • 14.3. BRICS
  • 14.4. European Union
  • 14.5. ASEAN
  • 14.6. GCC

15. Software as a Medical Device Market, by Country

  • 15.1. China
  • 15.2. United States
  • 15.3. Japan
  • 15.4. India
  • 15.5. Germany
  • 15.6. United Kingdom
  • 15.7. Australia
  • 15.8. France
  • 15.9. South Korea
  • 15.10. Italy
  • 15.11. Canada
  • 15.12. Russia
  • 15.13. Brazil
  • 15.14. Mexico
  • 15.15. Spain

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. AliveCor, Inc.
  • 17.3. Baxter International Inc.
  • 17.4. Becton, Dickinson and Company
  • 17.5. Biotronik SE & Co. KG
  • 17.6. Boston Scientific Corporation
  • 17.7. Cisco Systems, Inc.
  • 17.8. DexCom Inc.
  • 17.9. Edwards Lifesciences Corporation
  • 17.10. F. Hoffmann-La Roche Ltd.
  • 17.11. GE HealthCare Technologies Inc.
  • 17.12. Honeywell International Inc.
  • 17.13. IBM Corporation
  • 17.14. Intel Corporation
  • 17.15. Intuitive Surgical, Inc.
  • 17.16. iRhythm Technologies, Inc.
  • 17.17. Johnson & Johnson
  • 17.18. Koninklijke Philips N.V.
  • 17.19. Masimo Corporation
  • 17.20. Medtronic plc
  • 17.21. Microsoft Corporation
  • 17.22. Omron Healthcare, Inc.
  • 17.23. Oracle Corporation
  • 17.24. Qualcomm Life, Inc.
  • 17.25. ResMed Inc.
  • 17.26. Siemens Healthineers AG
  • 17.27. Smith & Nephew plc
  • 17.28. Stryker Corporation
  • 17.29. Terumo Corporation
  • 17.30. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MOBILE BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MOBILE BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MOBILE BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL STANDALONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL STANDALONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STANDALONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL WEB BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL WEB BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL WEB BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PREVENTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PREVENTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PREVENTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CLASS I MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CLASS I MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CLASS I MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CLASS II MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CLASS II MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CLASS II MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CLASS III MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CLASS III MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CLASS III MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHYSIOLOGICAL SIGNALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHYSIOLOGICAL SIGNALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHYSIOLOGICAL SIGNALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LABORATORY & GENOMIC DATA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LABORATORY & GENOMIC DATA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LABORATORY & GENOMIC DATA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PATIENT-REPORTED OUTCOMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PATIENT-REPORTED OUTCOMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PATIENT-REPORTED OUTCOMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARRHYTHMIA MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARRHYTHMIA MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARRHYTHMIA MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PRESSURE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PRESSURE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PRESSURE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEART FAILURE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HEART FAILURE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEART FAILURE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INSULIN DOSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INSULIN DOSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INSULIN DOSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NUTRITIONAL MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NUTRITIONAL MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NUTRITIONAL MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ORTHOPEDIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ORTHOPEDIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ORTHOPEDIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RESPIRATORY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RESPIRATORY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RESPIRATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AMBULATORY CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AMBULATORY CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AMBULATORY CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CLINICAL RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CLINICAL RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CLINICAL RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. NATO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. NATO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 158. NATO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 159. NATO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NATO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 161. NATO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 163. NATO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. G7 SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. G7 SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 168. G7 SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 170. G7 SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 172. G7 SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GCC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. GCC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 203. GCC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 206. GCC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 208. GCC SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. JAPAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. JAPAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 230. JAPAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 231. JAPAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 232. JAPAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. JAPAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 234. JAPAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. JAPAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 236. JAPAN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. INDIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. INDIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 239. INDIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 240. INDIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 241. INDIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. INDIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 243. INDIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. INDIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 245. INDIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GERMANY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. GERMANY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 248. GERMANY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 249. GERMANY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 250. GERMANY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. GERMANY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 252. GERMANY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. GERMANY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 254. GERMANY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED KINGDOM SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED KINGDOM SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED KINGDOM SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED KINGDOM SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED KINGDOM SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED KINGDOM SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED KINGDOM SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED KINGDOM SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 266. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 267. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 268. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 270. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 272. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. FRANCE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. FRANCE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 275. FRANCE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 276. FRANCE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 277. FRANCE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. FRANCE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 279. FRANCE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. FRANCE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 281. FRANCE SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 284. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 285. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 286. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 288. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 290. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. ITALY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 292. ITALY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 293. ITALY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 294. ITALY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 295. ITALY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. ITALY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 297. ITALY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. ITALY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 299. ITALY SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. CANADA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 301. CANADA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 302. CANADA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 303. CANADA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 304. CANADA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. CANADA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 306. CANADA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. CANADA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 308. CANADA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. RUSSIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. RUSSIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 311. RUSSIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 312. RUSSIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 313. RUSSIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 315. RUSSIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 316. RUSSIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 317. RUSSIA SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. BRAZIL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. BRAZIL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 320. BRAZIL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 321. BRAZIL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 322. BRAZIL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. BRAZIL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 324. BRAZIL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 325. BRAZIL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 326. BRAZIL SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. MEXICO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 328. MEXICO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 329. MEXICO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 330. MEXICO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY RISK CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 331. MEXICO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DATA INPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. MEXICO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 333. MEXICO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 334. MEXICO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 335. MEXICO SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 336. SPAIN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 337. SPAIN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 338. SPAIN SOFTWARE AS A MEDICAL DEVICE MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 339. SPAIN SOFTWARE AS A MEDICAL DEVICE M